Open clinical trial of rifabutin and clarithromycin therapy in Crohn's disease
- 1 January 2002
- journal article
- clinical trial
- Published by Elsevier BV in Digestive and Liver Disease
- Vol. 34 (1), 22-28
- https://doi.org/10.1016/s1590-8658(02)80055-x
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Use of short-term culture for identification of Mycobacterium avium subsp. paratuberculosis in tissue from Crohn's disease patientsClinical Microbiology & Infection, 2000
- Isolation of Mycobacterium avium subsp paratuberculosis from breast milk of Crohn's disease patientsThe American Journal of Gastroenterology, 2000
- Is Crohn's Disease an Immunodeficiency?Digestive Diseases and Sciences, 2000
- 4 Medical therapy of active Crohn's diseaseBailliere's Clinical Gastroenterology, 1998
- Activity of clarithromycin against intracellular Mycobacterium paratuberculosis — putative agent of Crohnʼs diseaseEuropean Journal of Gastroenterology & Hepatology, 1993
- Polymerase chain reaction detection of Mycobacterium paratuberculosis and Mycobacterium avium subsp silvaticum in long term cultures from Crohn's disease and control tissues.Gut, 1992
- Mycobacterium paratuberculosis DNA in Crohn's disease tissue.Gut, 1992
- Current concepts in the pathogenesis of Crohn's diseaseJournal of Gastroenterology and Hepatology, 1990
- Crohn's disease-isolated mycobacteria are identical to Mycobacterium paratuberculosis, as determined by DNA probes that distinguish between mycobacterial speciesJournal of Clinical Microbiology, 1987
- Characteristics of an unclassified Mycobacterium species isolated from patients with Crohn's diseaseJournal of Clinical Microbiology, 1984